Strata Skin Sciences, Inc. (SSKN) Stock Price & Analysis
Strata Skin Sciences, Inc. (SSKN) fell 19.33% to USD 0.12 as of June 10, 2026 at 06:57 UTC, according to Nexqual real-time market data.
SSKN last closed at USD 0.15; the session ranged USD 0.12–0.12 on volume of 611 shares. Market capitalization is $712,472, with a 52-week range of USD 0.11–3.86 (PNK). Source: Nexqual, June 10, 2026 at 06:57 UTC.
Key Statistics (as of June 10, 2026 at 06:57 UTC)
| Price | USD 0.12 |
|---|---|
| Change | ▼ 19.33% (down) |
| Previous Close | USD 0.15 |
| Open | USD 0.12 |
| Day Range | USD 0.12 – 0.12 |
| 52-Week Range | USD 0.11 – 3.86 |
| Volume | 611 shares |
| Market Cap | $712,472 |
| Exchange | PNK |
Technical Analysis (SSKN)
Nexqual's technical model rates SSKN "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 06:57 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 48.19 (neutral) |
| vs SMA50 | Below (USD 0.16) |
| MACD | -0.01 (negative) |
Analyst Ratings (SSKN)
Wall Street analysts rate SSKN "None", per Nexqual as of June 10, 2026 at 06:57 UTC.
| Consensus Rating | None |
|---|
Earnings (SSKN)
| Next Earnings Date | 2026-05-26 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-09-30 | USD -0.36 vs est -0.24 ▼ miss |
| 2025-06-30 | USD -0.6 vs est -0.27 ▼ miss |
| 2025-03-31 | USD -0.58 vs est -0.56 ▼ miss |
| 2024-12-31 | USD 0.29 vs est -0.4 ▲ beat |
Source: Nexqual, June 10, 2026 at 06:57 UTC.
Financials & Fundamentals (SSKN)
| Total Revenue | $30.70M |
|---|---|
| Revenue Growth (YoY) | -3.00% |
| Gross Margin | +58.25% |
| Operating Margin | +0.40% |
| Profit Margin | -20.40% |
| ROE | -158.91% |
| Debt / Equity | 559.42 |
| Current Ratio | 0.58 |
| Total Cash | $7.91M |
| Total Debt | $16.27M |
| Free Cash Flow | $-1.33M |
Source: Nexqual, June 10, 2026 at 06:57 UTC.
Financial Health Score (SSKN)
Nexqual rates Strata Skin Sciences, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 06:57 UTC.
| Growth | Mixed — Revenue +0.7% YoY (annual), slow |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Critical — $8M cash vs $16M debt |
| Cash Flow | Weak — FCF negative: -$1M, burning cash |
| Efficiency | Critical — ROE -159%, ROA -11.1% |
Ownership (SSKN)
| Insider Ownership | +9.97% |
|---|---|
| Institutional Ownership | +25.38% |
| Shares Outstanding | 5.89M |
| Float | 4.20M |
| Short % of Float | +8.13% |
Source: Nexqual, June 10, 2026 at 06:57 UTC.
Leadership (SSKN)
Strata Skin Sciences, Inc. is led by Dolev Rafaeli (age 61), President, CEO & Vice-Chairman, per Nexqual as of June 10, 2026 at 06:57 UTC.
| President, CEO & Vice-Chairman | Dolev Rafaeli (age 61) |
|---|---|
| Chief Operating Officer | Shmuel Gov (age 65) |
Major Backers & Investors (SSKN)
Notable institutional backers of Strata Skin Sciences, Inc. include Two Sigma Securities, LLC, according to Nexqual as of June 10, 2026 at 06:57 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Two Sigma Securities, LLC | 0.26% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 0.27% |
Source: Nexqual, June 10, 2026 at 06:57 UTC.
From Strata Skin Sciences, Inc.'s Latest SEC 10-K Filing (filed 2026-03-26)
Key Strengths & Strategy (as disclosed to the SEC)
- STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.
- It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments.
- The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne.
- It serves dermatologists and dermatological group clinics.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BGMSP | Bio Green Med Solution Inc. | USD 0.7 | ▲ 0.86% |
| SNOA | Sonoma Pharmaceuticals, Inc. | USD 1.11 | ▼ 2.63% |
| IPDN | Professional Diversity Network, | USD 0.63 | ▼ 3.08% |
| SNGX | Soligenix, Inc. | USD 0.43 | ▼ 2.95% |
| MNOV | MediciNova, Inc. | USD 1.27 | ▼ 3.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 06:57 UTC. This page is informational and not investment advice.